APA (7th ed.) Citation

Protzko, E., Bowman, L., Abelson, M., Shapiro, A., & Group, A. C. S. (2007). Phase 3 Safety Comparisons for 1.0% Azithromycin in Polymeric Mucoadhesive Eye Drops versus 0.3% Tobramycin Eye Drops for Bacterial Conjunctivitis. Investigative ophthalmology & visual science, 48(8), 3425-3429. https://doi.org/10.1167/iovs.06-1413

Chicago Style (17th ed.) Citation

Protzko, Eugene, Lyle Bowman, Mark Abelson, Aron Shapiro, and AzaSite Clinical Study Group. "Phase 3 Safety Comparisons for 1.0% Azithromycin in Polymeric Mucoadhesive Eye Drops Versus 0.3% Tobramycin Eye Drops for Bacterial Conjunctivitis." Investigative Ophthalmology & Visual Science 48, no. 8 (2007): 3425-3429. https://doi.org/10.1167/iovs.06-1413.

MLA (9th ed.) Citation

Protzko, Eugene, et al. "Phase 3 Safety Comparisons for 1.0% Azithromycin in Polymeric Mucoadhesive Eye Drops Versus 0.3% Tobramycin Eye Drops for Bacterial Conjunctivitis." Investigative Ophthalmology & Visual Science, vol. 48, no. 8, 2007, pp. 3425-3429, https://doi.org/10.1167/iovs.06-1413.